FR · biotech · gene therapy
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series A · Jan 2025 · €32M
Bpifrance lead, Novo Holdings A/S lead, Invus, Omnes Capital, UI Investissement, Fund+, Kurma Partners, Seroba Life Sciences, Turenne Capital
Reported by Silicon Canals
Missing a round, or an investor who was in one? Tell us.